Newsclip®: [Health] Boehringer's risankizumab induces remission in Crohn's patients in mid-stage study - AbbVie Inc. (NYSE:ABBV) | Seeking Alpha

"Interim results from a proof-of-concept Phase 2 clinical trial assessing Boehringer Ingelheim's investigational monoclonal antibody, risankizumab, for the",

0 comments | 1 clip



Last clipped by

Hey! Thanks for checking out Newsclip®!

Click on this Trending Newsclip® Stack to read other top media reports on this topic.

Be sure to clip to your personal newspaper, like, comment and share!

Newsclip® is the leader of Social News Discovery®.

Welcome to the Newsclip® beta release!

Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.

Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!

Invite Friends to Newsclip®

Invite your Facebook friends to follow you!

You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.